Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...

ATLANTA (AP) — U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisory committee backed another option to protect ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

In this article, we identify the top 10 most impactful articles for pediatric hospital medicine in 2025, as presented at the ...